COVID-19 booster shots are expected to drive demand for certain biologics ingredients and excipients at a faster pace than previously expected, with the growth rate estimated to increase 2%-5% by 2025.
Strong GDP and Population Growth
The market for personal care products in Africa is set to grow at a massive pace due to population increases. Already, the continent has the highest population growth in the world at a staggering 2.7% annually; if the trend persists, population is set to double by 2050, and Africa will be home to a quarter of the world’s population.
In addition, Africa’s overall GDP increase is broadening the market for personal care products as the African middle class grows.
Following the last session which aimed to provide a high-level overview of developments affecting the biocides industry, this webinar is now hosted by Kline’s Director and research team expert, Nikola Matic. He focuses on presenting the latest market developments in Europe and the USA and helps you understand key industry data, insights, and developments in major end-use applications driving the global biocides market and how they will change the industry within five years.
There have been a number of developments over the years in the biocides industry from regulatory clampdowns through to consolidations and divestments. This year we witnessed a record investment with the acquisition of Lonza Specialty Ingredients for US$4.7 billion a 13x EBITDA multiplier.
Regulations (mainly REACH, CLP, and BPR) have been changing the face of biocides in Europe over the last two decades and will continue shaping the market in the coming years. Some substances, such as OBPA (oxybishpenoxarsine), have been completely banned for years, while others, such as formaldehyde releasers, isothiazolinones, zinc pyrithione, zineb, and propiconazole, are currently facing regulatory pressure and uncertainty. All substances that are under close watch could see the appearance of a concentration limit, leading to a de facto phaseout, or it could be simply banned for use in all or several given applications.
Empty hard capsules (EHCs) are an effective alternative to the traditionally used tablet dosage forms in the pharmaceutical and nutrition industries. Despite having some disadvantages, such as higher costs and advanced technical requirements for manufacturing, hard capsules provide better dosage options for hygroscopic drugs, greater patient compliance, and are versatile dosage forms. Consequently, hard capsules were the second-leading oral solid-dosage form worldwide in 2020, after tablets. To learn more immediately read our recent article on how COVID-19 impacted Empty Hard Regional Markets.
Empty hard capsules (EHCs) are an effective alternative to the traditionally used tablet dosage forms in the pharmaceutical and nutrition industries. Despite having some disadvantages, such as higher costs and advanced technical requirements for manufacturing, hard capsules provide better dosage options for hygroscopic drugs, greater patient compliance, and are versatile dosage forms. Consequently, hard capsules were the second-leading oral solid-dosage form worldwide in 2020, after tablets. Continue reading
At Kline, we have been closely monitoring the impact of COVID-19 across the industry. At the same time, we are following the news on acquisitions and consolidations, including the recently announced potential sale or IPO of Diversey.
The household, industrial, and institutional (HI&I) cleaning chemicals market is an area of great potential for chemical suppliers. The growth in sales of cleaning products and thus ingredients consumption in household cleaning products is soaring during the COVID-19 pandemic’s phase of extreme sanitization. Globally, the household segment dominates this industry with more than a 77% share in ingredients sales value. Convenient formats, including more sustainable products that obtain efficient results, drive demand and future development of this segment.